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KCC2 is the neuron-specific K+-Cl cotransporter
required for maintaining low intracellular Cl, which
is essential for fast inhibitory synaptic transmission
in the mature CNS. Despite the requirement of
KCC2 for inhibitory synaptic transmission, under-
standing of the cellular mechanisms that regulate
KCC2 expression and function is rudimentary. We
examined KCC2 in its native protein complex in vivo
to identify key KCC2-interacting partners that
regulate KCC2 function. Using blue native-polyacryl-
amide gel electrophoresis (BN-PAGE), we deter-
mined that native KCC2 exists in a macromolecular
complex with kainate-type glutamate receptors
(KARs). We found that KAR subunits are required
for KCC2 oligomerization and surface expression.
In accordance with this finding, acute and chronic
genetic deletion of KARs decreased KCC2 function
and weakened synaptic inhibition in hippocampal
neurons. Our results reveal KARs as regulators of
KCC2, significantly advancing our growing under-
standing of the tight interplay between excitation
and inhibition.
INTRODUCTION
Hyperpolarizing GABAergic synaptic transmission in the mature
CNS depends upon a low concentration of intracellular Cl [Cl]i
KCC2 is the neuron-specificmember of the K+-Cl cotransporter
gene family that primarily extrudes Cl from neurons, making it
essential for inhibitory synaptic transmission (Acton et al.,
2012; Blaesse et al., 2009; Rivera et al., 1999). Physiological
levels of neuronal activity can regulate KCC2 in a Ca2+-depen-
dent manner to induce inhibitory synaptic plasticity, which plays
a key role in the delicate balance between inhibition and excita-
tion (Fiumelli and Woodin, 2007; Lamsa et al., 2010; Woodin1762 Cell Reports 7, 1762–1770, June 26, 2014 ª2014 The Authorset al., 2003). However, aberrant KCC2 regulation results in
increased neuronal Cl and contributes toward the pathophysi-
ology of numerous neurological disorders including epilepsy,
autism, and neuropathic pain (Coull et al., 2005; Kahle et al.,
2008; Tyzio et al., 2014; Woo et al., 2002).
KCC2 membrane expression and function are regulated by
multiple posttranslational mechanisms, including alterations in
phosphorylation state, oligomerization, association with lipid
rafts, and cleavage by proteases (Blaesse et al., 2006; Lee
et al., 2011; Puskarjov et al., 2012; Rinehart et al., 2009; Wata-
nabe et al., 2009). Recently, we made an important addition to
this list ofmechanisms that regulate KCC2 function by identifying
a KCC2-interacting protein termed Neto2 (Ivakine et al., 2013).
We found that Neto2 is required to maintain KCC2 abundance
in neurons and for efficient KCC2-mediated Cl transport.
Thus, the KCC2-Neto2 interaction is vital for normal synaptic in-
hibition in mature neurons.
Neto2 is a CUB domain containing transmembrane protein
that also acts as an auxiliary subunit of native kainate-type gluta-
mate receptors (KARs). Neto2 regulates both the kinetics and
synaptic localization of KAR subunits (Copits et al., 2011; Tang
et al., 2012; Wyeth et al., 2014; Zhang et al., 2009). KARs are
unique ionotropic glutamate receptors that perform multiple
functions during synaptic transmission and plasticity (Lerma
and Marques, 2013). They regulate GABAergic release from
presynaptic terminals (Rodrı´guez-Moreno et al., 1997), mediate
slow excitatory currents postsynaptically (Castillo et al., 1997),
and are involved in mossy fiber-pyramidal neuron long-term
potentiation in the CA3 area (Contractor et al., 2001).
Our identification of the Neto2-KCC2 interaction, coupled with
the previous demonstrations that Neto2 is an auxiliary subunit of
KARs, led us to ask whether KCC2 and KARs coexist in a macro-
molecular complex. In particular, we examined the role of GluK2
subunits that were previously shown to interact with Neto2
(Copits et al., 2011; Tang et al., 2011; Zhang et al., 2009). In
this study, we have made a surprising discovery that native
oligomeric KCC2 coexists in an ensemble with the GluK2 KAR
subunit in the CNS. Moreover, we determined that KARs
are required to maintain both KCC2 oligomerization and the
Figure 1. KCC2 Interacts with GluK2 KARs
in Mouse Brain and in Heterologous Cells
(A) Native KCC2 complexes fromC12E9-solubilized
whole-brain membrane fractions immunoprecipi-
tated with anti-KCC2 and immunoblotted with the
antibodies indicated at right (KCC2, GluK2/3,
Neto2). Representative example of three inde-
pendent replicates. IP, immunoprecipitate; I, input
fraction (1% of IP); U. unbound fraction (1% of IP);
O. oligomer; M. monomer; also see Figure S1A.
(B) (Bi) Coimmunoprecipitation experiments per-
formed in HEK293 cells transfected with KCC2 and
KAR subunits, solubilized in RIPA buffer, immu-
noprecipitated with anti-KCC2, and immuno-
blotted with the antibodies indicated at right
(KCC2, GluK2/3, myc); also see Figures S1B and
S1C. Representative example of three to four in-
dependent biological replicates (Bii) Quantitation
of the bound fractions to KCC2 was performed by
measuring the band intensity of the immunopre-
cipitated fraction compared with total input (10%)
using ImageJ software.
(C) Confocal images of DIV 12-14 cultured mouse
hippocampal neurons immunostained for endog-
enous KCC2 (left, green) and GluK1/2 (middle,
red), demonstrating that the two proteins are co-
localized (right, yellow). Representative of confocal
images obtained from 26 neurons over four inde-
pendent experiments performed using eight cov-
erslips. (Scale bars, 10 mm.) Bottom inset is a
magnification from the primary dendrite indicated
in the box.
All summary figures represent mean ± SEM. *p <
0.05, **p < 0.01, ***p < 0.001.expression of this transporter in the membrane. When we per-
formed an electrophysiological characterization of KCC2 func-
tion following KAR subunit disruption, we found neurons had
a depolarized reversal potential for GABA (EGABA). Hence, our
findings represent a regulation of KCC2 function and fast synap-
tic inhibition by components of excitatory transmission.
RESULTS
KCC2 and GluK2 KARs Interact In Vivo and In Vitro
We have recently discovered that KCC2 binds to the single-pass
CUB domain protein Neto2, and that this interaction is required
for efficient Cl extrusion in hippocampal neurons (Ivakine
et al., 2013). Several groups have previously established that
Neto2 is a critical auxiliary subunit of native KARs, including
GluK2 (Copits et al., 2011; Tang et al., 2011; Wyeth et al.,
2014; Zhang et al., 2009). This led us to hypothesize that KARsCell Reports 7, 1762–177might be a putative candidate that
could interact with KCC2. In order to
determine whether KCC2 interacts
with KAR subunits in vivo, we performed
a coimmunoprecipitation assay from
whole-brain native membrane prepara-
tions. We found that anti-KCC2 anti-
bodies coimmunoprecipitated GluK2/3primarily from wild-type mice in comparison to KCC2b+/
mice, indicating the existence of a KCC2-KAR complex in vivo
(Figures 1A and S1A; n = 3). To determine whether KCC2 can
interact with KARs independent of exogenous Neto2, we per-
formed coimmunoprecipitation experiments in HEK293 cells
transfected with KCC2 and KAR subunits alone. In this assay,
we found that KCC2 could coimmunoprecipitate GluK2, but
not GluK1 (Figures 1B and S1B; n = 4). We also performed the
experiment in the reverse direction and found that GluK2, but
not GluK1, could also robustly coimmunoprecipitate KCC2 (Fig-
ure S1C; n = 3). Based on the interaction of KCC2 and GluK2 in
these coimmunoprecipitation experiments, we hypothesized
that these two proteins would colocalize in neurons. We tested
this hypothesis by performing immunofluorescent staining of
endogenous proteins using antibodies specific for KCC2
and GluK1/2 in cultured hippocampal neurons, followed by
quantitative colocalization. Hippocampal neurons showed0, June 26, 2014 ª2014 The Authors 1763
Figure 2. Native KCC2 and KARs Exist in the
Same Oligomeric Complex
(A) One-dimensional BN-PAGE separation of
native KCC2 and GluK2/3 complexes from P30
mouse brain solubilized with Digitonin or C12E9; gel
separations were immunoblotted with the anti-
bodies indicated above (KCC2, GluK2/3). This blot
is a representative example of three independent
biological replicates. Native KCC2 is present as a
putative tetramer (blue arrow head), and as higher-
order protein complexes (green arrow heads).
Native GluK2/3 migrates in a similar molecular
weight range as native KCC2 (dotted yellow lines);
also see Figure S2A.
(B) (Bi) Antibody-shift assay followed by two-
dimensional BN-PAGE separation using C12E9-
solubilized whole-brain membrane fractions,
incubated with antibodies for HA or GluK2/3;
samples resolved first in a 5% 1D-BN-PAGE, and
individual lanes from the first dimension were
separated in a 6% 2D-SDS-PAGE); gel separa-
tions were immunoblotted with anti GluK2/3
antibody. (Bii and Biii) Similar to (Bi), but using
digitonin-solubilized hippocampal membrane
fractions and antibodies targeted to immunoglob-
ulin G or GluK2/3. Samples resolved in a 4% 1D-
BN-PAGE and 6% SDS-PAGE. Gel separations
were immunoblotted with KCC2 and Neto2 anti-
bodies respectively. Bottom panels in Bi, Bii, Biii
represent densitometric profiles and area under
the densitogram to indicate similar loading; red
arrowheads denote antibody-induced shifts in the
proteins indicated. Representative example of
three independent biological replicates; also see
Figures S2B–S2D.immunofluorescence for both endogenous KCC2 and KARs,
with a partial colocalization of these two proteins (Figure 1C;
n = 26). We then performed an intensity correlation analysis to
quantitate the colocalization and calculated a Pearson’s correla-
tion coefficient of 0.61 ± 0.03 between the GluK1/2 and KCC2
immunofluorescent signals, indicating 60% colocalization of
these proteins. Thus, we have discovered a surprising protein
interaction between KCC2 and the predominant kainate receptor
subunit, GluK2.
Native KCC2 Exists in a Hetero-Oligomeric Ensemble
with Native KARs
Functional KCC2 predominantly exists as an oligomer in the
mature brain (Blaesse et al., 2006; Ivakine et al., 2013; Uvarov
et al., 2009). Consistently, we observed that native KCC2 exist
as a putative tetramer and in higher-order complexes above
400 kDa (Figures 2A and S2A; n = 3), in P30 whole-brain mem-
brane lysates using a one-dimensional blue native polyacryl-
amide gel electrophoresis (1D-BN-PAGE). Similar to native
KCC2, we also observed higher-order complexes of comparable
molecular weights that contained native GluK2/3 (Figures 2A and
S2A). Next, to determine whether native KCC2 exists in an
ensemble with KAR subunits, we employed an antibody-shift
assay coupled with two-dimensional blue native polyacrylamide1764 Cell Reports 7, 1762–1770, June 26, 2014 ª2014 The Authorsgel electrophoresis (2D-BN-PAGE). The 2D-BN-PAGE strategy
has been previously employed to examine the native assemblies
of AMPA receptor multimeric complex (Schwenk et al., 2009).
Using this approach, we first verified that the addition of
the GluK2/3 antibody could shift GluK2/3 to higher molecular
weights (Figure 2Bi; n = 3). We observed that this antibody-
induced shift in GluK2/3 also shifted a population of native
KCC2 in hippocampal preparations (Figure 2Bii; n = 3). Using
the same experimental strategy, we found that KCC2 antibodies
could also shift a population of GluK2/3 in hippocampal prepara-
tions (Figure S2C; n = 3), a finding that we also observed
in digitonin-solubilized cortical membrane preparations (Fig-
ure S2D; n = 2). As a positive control for this assay, we probed
for Neto2, because this protein interacts with both KCC2
and GluK2 (Ivakine et al., 2013; Tang et al., 2011; Zhang et al.,
2009). As expected, we found that Neto2 could be shifted
with both GluK2/3 (Figure 2Biii) and KCC2 antibodies (Fig-
ure S2D). We confirmed the specificity of these interactions in
this assay by repeating the experiments using antibodies for
the transferrin receptor and observed that antibodies to this
receptor did not shift GluK2/3 (Figure S2B). Thus, we established
that functional oligomeric KCC2 coexists in a hetero-oligomeric
complex with the predominant KAR subunit GluK2 in hippocam-
pus and cortex.
Figure 3. GluK1/2-Null Hippocampal
Neurons Have an Increased Monomeric:
Oligomeric KCC2 Ratio
(A) Representative immunoblots of C12E9-solubi-
lized native lysates prepared in the presence of
25 mM iodoacetamide to prevent the formation of
nonspecific disulphide bonds between KCC2
monomers during membrane extraction, from
wild-type and GluK1/2-null hippocampi; resolved
in a standard 6% SDS-PAGE; immunoblotted with
the antibodies indicated at left (KCC2, NKCC1,
GluK2/3, ATP1A3, Tuj1). Also see Figure S3Ai.
(B) Samples obtained from the same preparation
as in (A) were resolved in the absence of DTT
in nondenaturing PFO-PAGE conditions. Red
arrowhead indicates the oligomeric KCC2 band
migrating above 400 kDa that is predominantly
reduced in GluK1/2/ lysates; blots shown in (A)
and (B) are representative of three independent
biological replicates, see Figures S3Aii and S4A.
(C) Summary figures showing levels of (Ci) KCC2
monomers, (Cii) KCC2 oligomers, (Ciii) total KCC2,
and (Civ) monomer:oligomer KCC2 ratio in GluK1/
2-null hippocampal homogenates relative to that of
wild-type.
(D) (Di) Example confocal microscopic immuno-
fluorescent images of cultured hippocampal neu-
rons from wild-type and GluK1/2-null mice stained
with anti-KCC2 antibody (red; n = 49 neurons).
(Scale bars, 24 mm.) (Dii) Summary of the average
fluorescence intensity of somatic KCC2 in wild-
type and GluK1/2-null neurons.
All summary figures represent mean ± SEM. *p <
0.05, **p < 0.01, ***p < 0.001.KARs Regulate the Assembly or Stability of Native KCC2
Oligomers
If oligomeric KCC2 exists in a complex with GluK2, and oligo-
meric KCC2 is the functional form of this transporter, this raises
the possibility that KARs may play an important role in the regu-
lation of KCC2 oligomers. To test this possibility, we examined
the ratio of KCC2 monomers to oligomers in native membranes
prepared from wild-type and GluK1/2-null hippocampal lysates
under conditions preventing the formation of nonspecific disul-
phide bonds (Uvarov et al., 2009). In an SDS-PAGE, we observed
an increase in monomeric KCC2 and a decrease in oligomeric
KCC2 in GluK1/2-null hippocampi (Figures 3A and S3Ai; n = 3).
We also examined the levels of the neuron-specific pump
ATP1A3 and another KCC2-family member NKCC1, and
observed no significant difference between wild-type and
GluK1/2-null lysates (Figure 3A). We reasoned that the dena-
turing gel running conditions of SDS-PAGE could impede a
robust quantification of KCC2 oligomeric levels, so we subse-Cell Reports 7, 1762–177quently chose to resolve changes in the
monomer:oligomer ratio using a previ-
ously established nondenaturing PFO-
PAGE (Uvarov et al., 2009). Using these
conditions, we observed a 2-fold increase
in monomeric KCC2 in GluK1/2-null
hippocampi (Figures 3B, 3Ci, and S3Aii;n = 3) as expected from the previous SDS-PAGE result. In addi-
tion, we also observed a significant decrease in oligomeric KCC2
levels above 400 kDa in GluK1/2-null hippocampi compared
with wild-type levels (Figures 3B, 3Cii, and S3Aii), and no signifi-
cant change in total KCC2 levels under the same conditions (Fig-
ure 3Ciii). We verified that there is no change in total KCC2 levels
by an additional standard approach by preparing the samples in
the absence of iodoacetamide, and resolved them under strong
denaturing conditions, indicating that there is no net change in
total KCC2 levels (Figure S3Aiii; n = 3). Additionally, we verified
that the increases inmonomeric KCC2 levels were not accompa-
nied by changes in KCC2 gene expression, by examining the
relative KCC2 mRNA abundance using quantitative real-time
PCR. We found no significant differences between wild-type
and GluK1/2-null hippocampi prepared from postnatal day 30
mice (Figure S3B; n = 3). Put together, these results demonstrate
that the presence of GluK1/2 determines the monomer:oligomer
ratio of KCC2 (Figure 3B and 3Civ) at the posttranscriptional0, June 26, 2014 ª2014 The Authors 1765
Figure 4. GluK1/2-Null Neurons Have
Deceased KCC2 Expressed at the Surface
(A) (Ai) Representative immunoblots of KCC2
monomers and oligomers from the surface and
internal fraction of wild-type and GluK1/2-null
neurons. The first two lanes correspond to bio-
tinylated surface proteins (50 mg) recovered from
the neutravidin beads. The last two lanes corre-
spond to unbiotinylated internal proteins (5 mg)
recovered from the supernatant. (Aii–v) Summary
figures showing levels of surface KCC2 mono-
mers, surface KCC2 oligomers, total surface KCC2
(normalized to surface levels of neuron-specific
ATP1A3), and internal KCC2 (normalized to b-actin
levels) in GluK1/2-null homogenates relative to that
of wild-type (n = 5).
(B) (Bi) Example confocal microscopic immuno-
fluorescent images from a single confocal plane of
live cultured hippocampal neurons overexpressing
KCC2-HA from wild-type and GluK1/2-null mice
(also see Figure S4B). Neuronal transfection is
indicated by GFP fluorescence, KCC2-HA is indi-
cated by red fluorescent signal. Summary of the
(Bii) average number of anti-HA puncta/neuron,
(Biii) percentage of anti-HA puncta proximal to the
surface (Biv) mean puncta size (surface area, mm
2),
and (Bv) puncta intensity (in arbitrary units x1000) in
wild-type and GluK1/2-null neurons. (Bvi) Total
immunofluorescence of live imaging of wild-type
and GluK1/2-null neurons. n = 23 neurons.
All summary figures represent mean ± SEM. *p <
0.05, **p < 0.01, ***p < 0.001.level. Moreover, by showing that loss of KAR subunits induces a
significant reduction in KCC2 oligomers, particularly above
400 kDa, we further strengthen our two major claims: (1) the
existence of a KAR:KCC2 hetero-oligomeric complex in the hip-
pocampus, and (2) KARs promote the assembly or the stability of
KCC2 oligomers within the complex.
KARs Maintain KCC2 Surface Expression in Neurons
It has been previously demonstrated by several groups that
immature neurons are characterized by predominantly mono-
meric KCC2 that exists intracellularly (reviewed in Chamma
et al., 2012). Based on these previous demonstrations, we exam-
ined whether there were differences in the expression patterns of
KCC2 between wild-type and GluK1/2/ neurons. We first1766 Cell Reports 7, 1762–1770, June 26, 2014 ª2014 The Authorsexamined total KCC2 levels by per-
forming immunofluorescent staining of
cultured hippocampal neurons with anti-
KCC2 antibody. We found a significant
increase in endogenous KCC2 immuno-
reactivity in the soma of GluK1/2/
neurons compared to wild-type neurons
(wild-type, n = 47; GluK1/2/, n = 49;
p < 0.001; Figure 3D). However, for
KCC2 to be functional it needs to be
expressed in the membrane. Next, we
examined the membrane expressionpattern of KCC2 by performing a surface biotinylation assay at
4C. We found a significant decrease in monomeric (p =
0.029), oligomeric (p = 0.029), and total (p = 0.008) KCC2 levels
in the surface of GluK1/2/ neurons compared to wild-type
neurons, with a corresponding increase in internal monomeric
KCC2 (p = 0.008; n = 5; Figure 4A). To visualize KCC2 expres-
sion, we performed live immunofluorescence of KCC2 contain-
ing an extracellular HA tag under nonpermeabilizing conditions
at 37C. We have previously demonstrated that this KCC2-HA
chimeric protein traffics to the membrane and is functional (Ac-
ton et al., 2012). We found that in GluK1/2/ neurons there
was a significant decrease the number of anti-HA puncta (Fig-
ure 4Bii; n = 23), with no significant differences in either the
size or intensity of the puncta (Figures 4Biv and 4Bv; n = 23),
Figure 5. Both Genetic Deletion and Acute
Knockdown of GluK2 KAR Subunits Depo-
larizes EGABA
(A) Example IV curves measuring EGABA from
cultured hippocampal neurons from wild-type (left)
and GluK1/2/ (middle) mice. Summary of EGABA
obtained from all similar IV curves (right).
(B) Example IV curves measuring EGABA from
cultured hippocampal neurons from wild-type
transfected with scrambled shRNA (left) and
shRNA for GluK2 (middle). Summary of EGABA ob-
tained from all similar IV curves.
(C) Summary of EGABA recordings performed in the
absence (control) and presence of the GluK2/5-
KAR inhibitor (5 mM UBP 310). Solid circles are
individual EGABA measurements, open triangles
represent the mean ± SEM. Insets: are raw voltage
clamp traces from example recordings.
Scale bars, 20 pA, 50 ms. Arrow indicates onset of
GABA puff. Dashed vertical lines indicate where
the current amplitudes were obtained for the
generation of the IV curves. All summary figures
represent mean ± SEM. *p < 0.05, **p < 0.01, ***p <
0.001.indicating an overall decrease in the number of KCC2-HA
puncta, with no difference in the puncta characteristics them-
selves. We then analyzed where the existing puncta were
located and found that there was a significant decrease in the
KCC2-HA puncta that were proximal to the membrane in
GluK1/2/ neurons (Figure 4Biii and S3; n = 23). We made two
important observations from these biotinylation and immuno-
staining experiments: (1) overall there is an increased total
KCC2 immunoreactivity in soma of GluK1/2/ neurons (Fig-
ure 3D); and (2) GluK1/2/ neurons have a decreased mem-
brane expression (Figure 4A). Thus, in addition to promoting
and/or stabilizing KCC2 oligomers, the presence of KAR sub-
units GluK1/2 also promotes and/or stabilizes surface KCC2
levels.
Genetic Deletion and Acute Silencing of KAR Subunits
Result in Depolarized EGABA
Because we observed a decrease in both oligomeric KCC2 and
surface KCC2 in GluK1/2-null neurons, we hypothesized that
these neurons would have aberrant KCC2-mediated Cl homeo-Cell Reports 7, 1762–177stasis. To test this hypothesis, we mea-
sured KCC2 activity by recording the
reversal potential for GABA (EGABA) using
gramicidin-perforated patch clamp re-
cordings. We found that EGABA was depo-
larized in cultured GluK1/2/ hippocam-
pal neurons (65.2 ± 1.9 mV; n = 10)
compared to wild-type neurons (78.6 ±
3.5; n = 7; p = 0.003; Figure 5A), with no
significant difference in either synaptic
conductance (p = 0.5) or maximum cur-
rent amplitude (p = 0.6; Table S2). We
then took a two-step approach to rule
out the possibility that the depolarizationof EGABA in GluK1/2
/ neurons was due to differences in activity
levels between the genotypes. First, we compared the sponta-
neous activity levels using Ca2+ imaging and found no differ-
ences between cultured hippocampal neurons prepared from
wild-type (C57/Bl6 and 129SVE) and GluK1/2/ mice (Fig-
ure S5A). Second, we used small hairpin RNA (shRNA) to acutely
silence GluK2 in cultured hippocampal neurons; we verified
GluK2 shRNA was effective at silencing GluK2 but not KCC2 us-
ing an in vitro assay (Figure S5B). We found that knocking down
GluK2 in wild-type neurons (C57/Bl6) depolarized EGABA by
15.41 mV compared to neurons transfected with scrambled
shRNA (Figures 5B and S5B; n = 11). Knocking down GluK2 in
129SVE wild-type neurons also significantly depolarized EGABA
(n = 11; p < 0.05). Similar to our results from cultured GluK1/
2/ hippocampal neurons above, we found no significant differ-
ence in either synaptic conductance (p = 0.6) or maximum cur-
rent amplitude (p = 0.1) for either genotype (Table S2). Last, we
considered the possibility that the depolarization in EGABA we re-
corded following the genetic deletion and acute silencing of KAR
subunits was not due to the loss of the protein, but rather was0, June 26, 2014 ª2014 The Authors 1767
due to the loss of the GluK2-KAR current. We tested this possi-
bility by recording EGABA in wild-type neurons in the presence
and absence of the GluK2/5-KAR antagonist UBP 310 (5 mM)
(Pinheiro et al., 2013).We found no significant difference in EGABA
following this pharmacological blockade of these receptors (n =
5; p = 0.159; Figure 5C), allowing us to conclude that it is the
protein interaction between GluK2-KARs and KCC2 that is
required to maintain a high KCC2 function.
DISCUSSION
Overall, we have three compelling lines of evidence supporting
the conclusion that KCC2 and KAR subunits coexist in a
complex: (1) in vivo and in vitro coimmunoprecipitation, (2)
antibody-shift assay coupled with 2D-BN-PAGE, and (3) immu-
nofluorescence. Thus, the key K+-Cl cotransporter required
for fast synaptic inhibition binds to the predominant KAR-type
ionotropic glutamate receptor subunit GluK2 in multiple brain re-
gions including hippocampus. Furthermore, we find that the
GluK2:KCC2 interaction occurs predominantly with oligomeric
KCC2, and the importance of this preferential binding is to main-
tain the functional oligomeric KCC2 complex. Along with our
evidence that both genetic deletion and acute knockdown of
GluK2 result in aberrant KCC2-dependent neuronal Cl extru-
sion, we have identified kainate receptors as an unexpected
player during neuronal Cl homeostasis.
Functional KCC2 Exists as a Hetero-Oligomeric
Complex with KARs
Several studies have established that functional KCC2 predom-
inantly exists as oligomers in mature neurons (Blaesse et al.,
2006; Ivakine et al., 2013; Uvarov et al., 2009; Watanabe et al.,
2009). Here, we report using BN-PAGE that the majority of olig-
omeric KCC2 in mature brain migrates above 400 kDa. The key
finding of this study is that GluK2 is a member of this KCC2-het-
eromeric complex. This finding raises an important question: is
this complex exclusive to KCC2 and GluK2, or do these com-
plexes also include Neto2 and other proteins? This question is
relevant because we recently identified that Neto2 associates
with oligomeric KCC2 (Ivakine et al., 2013). Our current data
demonstrate that, whereas KCC2 and Neto2 interact, Neto2 is
not required for the GluK2:KCC2 interaction because GluK2
and KCC2 can interact in the absence of exogenous Neto2 in
heterologous cells. Despite the fact that Neto2 is not required
for the GluK2:KCC2 interaction, this does not discount the pos-
sibility that these three proteins commonly exist in a heteromeric
complex. Moreover, there is another reason to believe that addi-
tional proteins may also coexist in this heteromeric complex. For
example, the 4.1N protein has been identified as binding part-
ners of both KCC2 (Li et al., 2007) and more recently GluK2
(Copits and Swanson, 2013). Because the 4.1 family of FERM
domain proteins are abundant scaffolds between membrane
and cytoskeletal proteins (Baines et al., 2013), it is possible to
speculate that the GluK2:KCC2 interaction we have identified
could be mediated/stabilized by neuronal FERM domain pro-
teins. Interestingly, while this manuscript was in revision another
group discovered that the dwell time of KCC2 in the vicinity of
excitatory synapses is determined by its interactions with 4.1N1768 Cell Reports 7, 1762–1770, June 26, 2014 ª2014 The Authors(Chamma et al., 2013), further strengthening our claims about
the putative participation of the 4.1N protein within the KCC2:
KAR hetero-oligomeric complex.
KCC2 Oligomerization and Surface Expression Depend
on GluK2-KARs
We found that GluK1/2-null hippocampal neurons have a
decrease in KCC2 oligomers, particularly above 400 kDa. This
suggests that GluK2 plays a role in either the formation of
KCC2 oligomers and/or regulates their stability, but how might
this happen? The answer may lie in the fact that GluK2-null
hippocampi have an 50% reduction in Neto2 protein levels
(Figures 4A and S4A), and we know that Neto2 is required for
KCC2 oligomerization and the efficacy of KCC2 transport (Iva-
kine et al., 2013). Does this mean that GluK2 regulates KCC2
via only Neto2, or can it directly regulate KCC2 function? Our
current results suggest that GluK2 can also regulate KCC2 inde-
pendently of Neto2. We found that in GluK1/2/ neurons there
was an increase in KCC2 monomers and a decrease in KCC2
oligomers, with no net change in total KCC2 levels. This is in
contrast to our previous finding that Neto2-null neurons have
an overall decrease in both monomeric and oligomeric KCC2,
which results in a total decrease in KCC2 protein levels (Ivakine
et al., 2013).
Results from our biotinylation experiments allowed us to
conclude that GluK1/2/ neurons have a decrease in cell-sur-
face KCC2. Thus, in addition to promoting or stabilizing KCC2
oligomers GluK1/2-KARs also maintain and/or stabilize surface
KCC2 levels. We supported these findings by immunostaining
for KCC2; using standard fixed immunofluorescence, we found
an increase in somatic KCC2 levels, whereas live immunofluo-
rescence of KCC2-HA showed a decrease in the number of
anti-KCC2-HA puncta. Although anti-KCC2-HA puncta must
have been present on the surface at some point during the
experiment, we cannot conclude that our puncta analysis repre-
sents only membrane expressed protein. At the temperature
these experiments were performed (37C), we would expect
some proportion of KCC2-HA would be endocytosed, especially
considering that KCC2 membrane turnover has been reporter to
be relatively high (Lee et al., 2010, but see also Puskarjov et al.,
2012). Thus, the KCC2 puncta we have quantified may represent
a combination of KCC2-HA in the membrane and endocytotic
vesicles. Thus, although we are able to conclude that the loss
of GluK2-KARs decreases KCC2 membrane expression, future
studies should address whether GluK2 also regulates KCC2
membrane turnover. Together, the increase in KCC2 monomers
and decrease in membrane expression suggests that GluK1/
2/ neurons resemble immature neurons, which have an abun-
dance of cytoplasmic KCC2monomers (Gulya´s et al., 2001). Our
electrophysiological data support this observation of an imma-
ture Cl homeostasis phenotype, where the genetic deletion of
GluK1/2 is reminiscent of immature neurons with poor Cl extru-
sion, suggesting that kainate receptors are an essential compo-
nent of mature neuronal Cl homeostasis.
Conclusions and Future Significance
The significance of our findings are manifold, but most impor-
tantly: (1) KCC2 and KARs exist in the same macromolecular
complex, and (2) an ionotropic glutamate receptor can positively
regulate the function of the predominant neuronal Cl cotrans-
porter KCC2. These findings have important implications for
both normal physiological functions of neuronal networks and
for pathophysiological conditions that result from dysfunction
of KARs and KCC2. At the physiological level, we have demon-
strated that both genetic deletion and acute knockdown of
GluK2 weakens synaptic inhibition, suggesting that the co-
existence of these proteins provides a nexus for the ongoing
maintenance of the excitatory-inhibitory balance. At the patho-
physiological levels, both KCC2 and KARs are strongly impli-
cated in neurological disorders, including neuropathic pain
(Bhangoo and Swanson, 2013), autism (Tyzio et al., 2014), and
epilepsy (Woo et al., 2002). This raises the possibility that the
disruption of the KCC2:KAR complex may underlie these neuro-
physiological disorders. Understanding the fundamental molec-
ular pathways that regulate the cell intrinsic excitation, inhibition




All experiments were performed in accordance with approval and guidelines
from the University of Toronto Animal Care Committee and the Canadian
Council on Animal Care. Animals of both sexes were used to prepare hippo-
campal cultures; all other experiments were performed on male mice. The
following animal species were used:
d Wild-type C57/Bl6 (Charles River Laboratories)
d Wild-type 129/SV (Charles River Laboratories)
d GluK1/2/ maintained on a mixed 129SV/C57Bl6 background
d KCC2+/ maintained on a mixed 129SV/C57Bl6 background
Antibodies
See Table S1 for complete details for all antibodies used in this study.
Biochemistry and Molecular Biology
See Supplemental Experimental Procedures for coimmunoprecipitation anal-
ysis, PFO-PAGE, BN-PAGE, antibody-shift assay, PCR, surface biotinylation.
Hippocampal Cultures and Electrophysiology
Low-density cultures of dissociated mouse hippocampal neurons were
prepared as previously described (Acton et al., 2012). Experiments were
performed after 10–13 days in culture. Gramicidin perforated patch clamp re-
cordings were performed as previously described (Acton et al., 2012). See
Supplemental Experimental Procedures for details on culturing and electro-
physiology, shRNA, and neuronal transfection.
Immunostaining, Confocal Microscopy, Ca2+ Imaging
Live immunostaining was performed as described before (Acton et al., 2012).
See Supplemental Experimental Procedures for details on fixed and live immu-
nostaining, confocal microscopy, and Ca2+ imaging.
Statistics
Results are given as mean ± SEM. See Supplemental Experimental Proce-
dures for details on statistical tests used for individual figures.
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